News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
FDA OKs First Biosimilar
Tracy Vence | Mar 6, 2015
The US Food and Drug Administration approves Sandoz’s Zarxio, a biosimilar to Amgen’s filgrastim, which is mainly prescribed for cancer patients.
HHS Rolls Out Public Access Plans
Tracy Vence | Mar 3, 2015
The US Department of Health and Human Services outlines how the National Institutes of Health and its other agencies will make research results public.
Bob Grant | Mar 1, 2015
Evolving Ourselves, The Man Who Touched His Own Heart, Bats
FDA OKs 23andMe Test
Kerry Grens | Feb 20, 2015
The US Food and Drug Administration will allow the personal genomics company to resume a disease-risk analysis.
Clinic Trial Problems Kept Mum
Kerry Grens | Feb 11, 2015
Despite documented dysfunction in a number of studies, rarely do those problems get a mention in the resulting publications, according to a new study.
FDA Head Leaving Post
Kerry Grens | Feb 6, 2015
US Food and Drug Administration commissioner Margaret Hamburg is stepping down after six years on the job.
Kate Yandell | Feb 1, 2015
While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.
Jyoti Madhusoodanan | Jan 1, 2015
Chinese farmers’ efforts at rearing wild animals may benefit conservation and reduce human health risks.
Science Setbacks: 2014
Molly Sharlach | Dec 25, 2014
This year in life science was marked by paltry federal funding increases, revelations of sequence contamination, and onerous regulations.
Top Science Scandals of 2014
Jef Akst | Dec 25, 2014
The stem cell that never was; post-publication peer review website faces legal trouble; biosecurity breaches at federal labs